States and UT must decide on opening of on-site registrations/facilitated cohorts' registration and appointments for 18-44 years age group as an additional measure to minimise vaccine wastage and for facilitating vaccination of eligible beneficiaries in the age group of 18-44 years, the ministry said in its statement.
Moderna's study included 3,732 adolescents from ages 12 to 17 enrolled at sites across the U.S. If Moderna gets the same treatment, its authorization would come in early July.
Moderna, whose vaccine is authorised for adults 18 and older, aims to be next in line, saying it will submit its teen data to the US Food and Drug Administration and other global regulators for emergency use authorisation in early June. Preliminary findings showed the vaccine triggered the same signs of immune protection in kids as it does in adults, and the same kind of temporary side effects such as sore arms, headache and fatigue. Covaxin, which is manufactured by Bharat Biotech, was out of stock for 18-44 age groups for the last two weeks and now Covishield manufactured by Serum Institute of India (SII) too have gone out of stock now.More news: At least eight dead in Italian cable vehicle accident
Guleria also said there is no evidence yet to prove that children will be more affected in the third wave. Widely vaccinating 12- to 18-year olds could allow US schools and summer camps to relax masking and social distancing measures suggested by the CDC.
The researchers found no new safety issues.
The company said it is still accumulating safety data. The teenagers in the study will be monitored for a year after their second dose, the New York Times reported.More news: Video shows Ronald Greene ordered facedown in deadly Louisiana arrest
Moderna Inc says its coronavirus vaccine appears to be safe and effective in children ages 12 to 17. "Depending on the surplus available with them, they will get back to the government of India", Lav Agarwal, joint secretary, health ministry, said during a press conference on Covid-19 situation. At least 316 have died in the USA alone, as per a tally by the American Academy of Pediatrics.
In the case of Pfizer, the USA pharma giant has indicated availability of 5 crore vaccine doses - 1 crore in July, 1 crore in August, 2 crore in September and 1 crore in October -for supply to India in 2021 and that it will deal only with Government of India and payment for vaccines will have to be made by GOI to Pfizer India.
In a recent poll, conducted by the Kaiser Family Foundation, parents were asked if they would get their child immunized once a COVID-19 vaccine is authorized and available for their child's age group.More news: Nyiragongo volcano has erupted